Cellular pharmacology of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937 (Q71730042)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7554040%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Cellular pharmacology of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7554040%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

D H Horber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7554040%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

H Schott

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7554040%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

R A Schwendener

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7554040%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7554040%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7554040%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7554040%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7554040%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

483-492

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7554040%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00685798

20 October 2019

exact match

0 references

cites work

Sequential hydroxyurea-cytarabine chemotherapy for refractory non-Hodgkin's lymphoma

1 reference

12 December 2020

High dose cytarabine: a review

1 reference

12 December 2020

Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies

1 reference

12 December 2020

Antitumor activities of newly synthesized N4-acyl-1-beta-D-arabinofuranosylcytosine

1 reference

12 December 2020

Detection of 1-beta-D-arabinofuranosylcytosine incorporation into DNA in vivo

1 reference

12 December 2020

Cytidine deaminase and the development of resistance to arabinosyl cytosine.

1 reference

12 December 2020

Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity

1 reference

12 December 2020

Terminal erythroid differentiation in the K-562 cell line by 1-beta-D-arabinofuranosylcytosine: accompaniment by c-myc messenger RNA decrease

1 reference

12 December 2020

N4-Behenoyl-1-beta-D-arabinofuranosylcytosine as a potential new antitumor agent

1 reference

12 December 2020

Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells

1 reference

12 December 2020

Improved prospects for long-term survival in adults with acute myelogenous leukemia

1 reference

12 December 2020

Cellular pharmacology of 1-beta-D-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cells

1 reference

12 December 2020

Nucleoside conjugates as potential antitumor agents. 2. Synthesis and biological activity of 1-.beta.-D-arabinofuranosylcytosine conjugates of prednisolone and prednisone

1 reference

12 December 2020

Therapy of refractory/relapsed acute leukemia with cytosine arabinoside plus tetrahydrouridine (an inhibitor of cytidine deaminase)--a pilot study

1 reference

12 December 2020

Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase

1 reference

12 December 2020

Treatment of acute myelogenous leukemia in adults with N4-behenoyl-1-beta-D-arabinofuranosylcytosine

1 reference

12 December 2020

Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytes

1 reference

12 December 2020

Antitumor properties of 2(1H)-pyrimidinone riboside (zebularine) and its fluorinated analogues.

1 reference

12 December 2020

Biochemistry of azacitidine: a review.

1 reference

12 December 2020

Arabinosyl-5-azacytosine: mechanisms of native and acquired resistance.

1 reference

12 December 2020

Inducers of erythroid differentiation in K562 human leukemia cells

1 reference

12 December 2020

Biochemistry and clinical activity of N-(phosphonacetyl)-L-aspartate: a review

1 reference

12 December 2020

Nucleosides. XLVII. Syntheses of some N4-substituted derivatives of 1-.beta.-D-arabinofuranosylcytosine and -5-fluorocytosine

1 reference

12 December 2020

Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma

1 reference

12 December 2020

Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential

1 reference

12 December 2020

Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin

1 reference

12 December 2020

Treatment of Acute Leukemia–Advances in Chemotherapy, Immunotherapy, and Bone Marrow Transplantation

1 reference

12 December 2020

Substrate-specific deoxycytidine kinase deficiency in 1-beta-D-arabinofuranosylcytosine-resistant leukemic cells

1 reference

12 December 2020

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

12 December 2020

Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function

1 reference

12 December 2020

In vivo cellular kinetic and pharmacological studies of 1-beta-D-arabinofuranosylcytosine and 3-deazauridine chemotherapy for relapsing acute leukemia

1 reference

12 December 2020

Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.

1 reference

12 December 2020

Role of deoxycytidine kinase in an in vitro model for AraC- and DAC-resistance: substrate-enzyme interactions with deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-aza-2'-deoxycytidine

1 reference

12 December 2020

Prevention of 1-beta-D arabinofuranosylcytosine toxicity by 4-nitrobenzyl-6-thioinosine or dipyridamole in human leukemia cell lines.

1 reference

12 December 2020

Rapid isolation of neuroblastoma plasma membranes on Percoll gradients. Characterization and lipid composition.

1 reference

12 December 2020

Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in patients with acute leukemia.

1 reference

12 December 2020

Enzyme catalyzation of the deacylation of N4-acyl derivatives of 1-beta-D-arabinofuranosylcytosine in the mouse liver microsome

1 reference

12 December 2020

Effects of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on blast progenitors of acute myeloblastic leukemia

1 reference

12 December 2020

Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia

1 reference

12 December 2020

Treatment of L1210 murine leukemia with liposome-incorporated N4-hexadecyl-1-beta-D-arabinofuranosyl cytosine

1 reference

12 December 2020

Pharmacokinetic properties and interactions with blood components of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine (NHAC) incorporated into liposomes

1 reference

12 December 2020

Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes

1 reference

12 December 2020

Pyrimidine nucleosides. 6. Synthesis and anticancer activities of N4-substituted 2,2'-anhydronucleosides

1 reference

12 December 2020

Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia

1 reference

12 December 2020

Modulation of cytarabine uptake and toxicity by dipyridamole

1 reference

12 December 2020

Induction of terminal differentiation in human K562 erythroleukemia cells by arabinofuranosylcytosine

1 reference

12 December 2020

Phospholipid derivatives of nucleoside analogs as prodrugs with enhanced catabolic stability

1 reference

12 December 2020

Cellular pharmacodynamics of anticancer drugs

1 reference

12 December 2020

Development of resistance to 1-beta-D-arabinofuranosylcytosine after high-dose treatment in childhood lymphoblastic leukemia: analysis of resistance mechanism in established cell lines

1 reference

12 December 2020

The genetic origin of drug resistance in neoplasms: implications for systemic therapy.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00685798

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7554040%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference